Key Clinical Trial Data on Current and Emerging Therapeutic Approaches: ICI and TKI for nccRCC
The France Foundation
Key Clinical Trial Data on Current and Emerging Therapeutic Approaches: ICI and TKI for nccRCC
34:23
Complexities in the Diagnosis of nccRCC: How Can We Do Better?
The France Foundation
Complexities in the Diagnosis of nccRCC: How Can We Do Better?
46:56
Myotonic Dystrophy Type 1: Mechanism of Disease
The France Foundation
Myotonic Dystrophy Type 1: Mechanism of Disease
1:37
Myotonic Dystrophy Type 1 (DM1) - Considerations for Exercise Management Discussion (Video 4/4)
The France Foundation
Myotonic Dystrophy Type 1 (DM1) - Considerations for Exercise Management Discussion (Video 4/4)
5:42
Myotonic Dystrophy Type 1 (DM1) - Multidisciplinary Care Panel Discussion (Video 3/4)
The France Foundation
Myotonic Dystrophy Type 1 (DM1) - Multidisciplinary Care Panel Discussion (Video 3/4)
4:29
Myotonic Dystrophy Type 1 (DM1) - Improving Diagnosis Panel Discussion (Video 2/4)
The France Foundation
Myotonic Dystrophy Type 1 (DM1) - Improving Diagnosis Panel Discussion (Video 2/4)
4:32
Myotonic Dystrophy Type 1 (DM1) - Disease Overview Panel Discussion (Video 1/4)
The France Foundation
Myotonic Dystrophy Type 1 (DM1) - Disease Overview Panel Discussion (Video 1/4)
5:52
Importance of a Multidisciplinary Patient-Centered Approach for Optimizing Care of People With HCC
The France Foundation
Importance of a Multidisciplinary Patient-Centered Approach for Optimizing Care of People With HCC
56:55
Symposium A New Era for Hemophilia Treatment Common Goals, Unique Perspectives
The France Foundation
Symposium A New Era for Hemophilia Treatment Common Goals, Unique Perspectives
1:58:25
The Critical Role of the Radiologist in the Diagnosis of Bronchiectasis
The France Foundation
The Critical Role of the Radiologist in the Diagnosis of Bronchiectasis
36:39
Immunotherapy in the Management of Advanced Biliary Tract Cancer (BTC)
The France Foundation
Immunotherapy in the Management of Advanced Biliary Tract Cancer (BTC)
36:23
Emerging Evidence on Immunotherapy for HCC Management in Early Stages
The France Foundation
Emerging Evidence on Immunotherapy for HCC Management in Early Stages
1:01:41
Translating Data Into Practice: The Role of Immunotherapy in the Management of Advanced HCC
The France Foundation
Translating Data Into Practice: The Role of Immunotherapy in the Management of Advanced HCC
57:08
Emerging Evidence on Immunotherapy for HCC Management in Intermediate Stages
The France Foundation
Emerging Evidence on Immunotherapy for HCC Management in Intermediate Stages
59:48
Translating Data Into Practice: The Role of Immunotherapy in the Management of Advanced HCC
The France Foundation
Translating Data Into Practice: The Role of Immunotherapy in the Management of Advanced HCC
57:08
Considering a Comprehensive Approach for Bronchiectasis Management
The France Foundation
Considering a Comprehensive Approach for Bronchiectasis Management
55:01
Advances in the Diagnosis, Assessment, and Therapeutic Management of BTC
The France Foundation
Advances in the Diagnosis, Assessment, and Therapeutic Management of BTC
36:05
Cognitive Impairment Associated with Schizophrenia
The France Foundation
Cognitive Impairment Associated with Schizophrenia
1:01:06
Negative and Cognitive Symptoms  A Focus on Digital Therapeutics
The France Foundation
Negative and Cognitive Symptoms A Focus on Digital Therapeutics
32:47
Caring for Your Patients with ATTR
The France Foundation
Caring for Your Patients with ATTR
57:04
Expert Perspectives  The Role of Immunotherapy in Advancing the Treatment of HCC and BTC
The France Foundation
Expert Perspectives The Role of Immunotherapy in Advancing the Treatment of HCC and BTC
1:08:08
Cleveland Clinic Tall Rounds: Treating Confirmed ATTR
The France Foundation
Cleveland Clinic Tall Rounds: Treating Confirmed ATTR
59:35
Weight Management in Community Health: Bridging Systems & Care Coordination
The France Foundation
Weight Management in Community Health: Bridging Systems & Care Coordination
1:08:27
Contemporary Strategies: Diagnosing ATTR Amyloidosis
The France Foundation
Contemporary Strategies: Diagnosing ATTR Amyloidosis
1:01:59
Improving the Diagnosis and Management of PFF: A Focus on SSc-ILD and IPF
The France Foundation
Improving the Diagnosis and Management of PFF: A Focus on SSc-ILD and IPF
42:33
Improving the Management of Patients with DMD: Emerging Evidence & Treatment Strategies
The France Foundation
Improving the Management of Patients with DMD: Emerging Evidence & Treatment Strategies
40:04
RSV Illness at Risk Populations
The France Foundation
RSV Illness at Risk Populations
8:44
RSV Illness Resource Use and Cost Burdens for Older Adults
The France Foundation
RSV Illness Resource Use and Cost Burdens for Older Adults
6:18
RSV Illness Vaccination Benefits
The France Foundation
RSV Illness Vaccination Benefits
9:30
What do you Know About RSV in Adults
The France Foundation
What do you Know About RSV in Adults
3:19
Yes, it Happens RSV Illness in Adults
The France Foundation
Yes, it Happens RSV Illness in Adults
31:57
RSV vs Influenza in Hospitalized Adults ≥ 60 years Old
The France Foundation
RSV vs Influenza in Hospitalized Adults ≥ 60 years Old
8:39
Addressing DMD Time to Diagnosis - Impact of Early Diagnosis
The France Foundation
Addressing DMD Time to Diagnosis - Impact of Early Diagnosis
8:06
Screening for, Assessing, and Diagnosing DMD
The France Foundation
Screening for, Assessing, and Diagnosing DMD
6:57
Addressing DMD Time to Diagnosis - Obstacles to Diagnosis
The France Foundation
Addressing DMD Time to Diagnosis - Obstacles to Diagnosis
7:17
Addressing DMD Time to Diagnosis - First Clinical Suspicion
The France Foundation
Addressing DMD Time to Diagnosis - First Clinical Suspicion
6:53
Addressing DMD Time to Diagnosis - Newborn Screening for DMD
The France Foundation
Addressing DMD Time to Diagnosis - Newborn Screening for DMD
5:26
Addressing DMD Time to Diagnosis - The Role of Genetic Testing for Diagnosing DMD
The France Foundation
Addressing DMD Time to Diagnosis - The Role of Genetic Testing for Diagnosing DMD
4:26
Complications of Duchenne Muscular Dystrophy
The France Foundation
Complications of Duchenne Muscular Dystrophy
10:23
Addressing DMD Time to Diagnosis - Consequences of Delayed Diagnosis
The France Foundation
Addressing DMD Time to Diagnosis - Consequences of Delayed Diagnosis
5:11
Multidisciplinary Management of Duchenne Muscular Dystrophy
The France Foundation
Multidisciplinary Management of Duchenne Muscular Dystrophy
6:33
Logistical Considerations for Long-term Care of Patients With Duchenne Muscular Dystrophy
The France Foundation
Logistical Considerations for Long-term Care of Patients With Duchenne Muscular Dystrophy
6:49
The Role of the Primary Care Provider in Duchenne Muscular Dystrophy
The France Foundation
The Role of the Primary Care Provider in Duchenne Muscular Dystrophy
6:51
Recognizing the Signs and Symptopms of Duchenne Muscular Dystrophy
The France Foundation
Recognizing the Signs and Symptopms of Duchenne Muscular Dystrophy
9:16
PNH Animation - The Complement System and PNH Pathophysiology
The France Foundation
PNH Animation - The Complement System and PNH Pathophysiology
5:06
PNH Animation - Therapies Targeting Complement Pathways in PNH
The France Foundation
PNH Animation - Therapies Targeting Complement Pathways in PNH
5:45
Hemophilia AAV Gene Therapy Animation
The France Foundation
Hemophilia AAV Gene Therapy Animation
2:25
Evolutions in the Management of Duchenne Muscular Dystrophy: Case Discussion
The France Foundation
Evolutions in the Management of Duchenne Muscular Dystrophy: Case Discussion
8:57
Evolutions in the Management of Duchenne Muscular Dystrophy: Therapies for DMD
The France Foundation
Evolutions in the Management of Duchenne Muscular Dystrophy: Therapies for DMD
29:01
Evolutions in the Management of Duchenne Muscular Dystrophy: Introduction to Dystrophin
The France Foundation
Evolutions in the Management of Duchenne Muscular Dystrophy: Introduction to Dystrophin
6:42
GLP 1 RAs  Real World Patient Care Strategies for Type 2
The France Foundation
GLP 1 RAs Real World Patient Care Strategies for Type 2
50:57
Living with MS - Patient Needs at Diagnosis
The France Foundation
Living with MS - Patient Needs at Diagnosis
2:28
Living with MS - A Discussion Between a Physician and Patient on Selecting Treatment Options
The France Foundation
Living with MS - A Discussion Between a Physician and Patient on Selecting Treatment Options
2:59
Living with MS - Patient Needs at Diagnosis
The France Foundation
Living with MS - Patient Needs at Diagnosis
2:48
Multimodal Management of OUD (Animation 2 of 2)
The France Foundation
Multimodal Management of OUD (Animation 2 of 2)
1:50
Educating a Patient About Multimodal Pain (Animation 1 of 2)
The France Foundation
Educating a Patient About Multimodal Pain (Animation 1 of 2)
1:52
Advances in Nonvalvular Atrial Fibrillation: Exploring Undiagnosed NVAF and Comorbidities
The France Foundation
Advances in Nonvalvular Atrial Fibrillation: Exploring Undiagnosed NVAF and Comorbidities
22:57
Insights Into Advances in Nonvalvular Atrial Fibrillation: Enhancing NVAF Recognition
The France Foundation
Insights Into Advances in Nonvalvular Atrial Fibrillation: Enhancing NVAF Recognition
18:13
Insights Into Advances in Nonvalvular Atrial Fibrillation: Creating Patient-centric Treatment Plans
The France Foundation
Insights Into Advances in Nonvalvular Atrial Fibrillation: Creating Patient-centric Treatment Plans
34:24
The Patient Perspective  Continuous Glucose Monitoring CGMs
The France Foundation
The Patient Perspective Continuous Glucose Monitoring CGMs
32:23
Relapse, Progression, and Treatment of the Patient with MS
The France Foundation
Relapse, Progression, and Treatment of the Patient with MS
56:04
The Role of B Cells in Progressive MS and the Long term Effects of B Cell Depletion
The France Foundation
The Role of B Cells in Progressive MS and the Long term Effects of B Cell Depletion
23:30
Biomarker Strategies for Lysosomal Diseases
The France Foundation
Biomarker Strategies for Lysosomal Diseases
18:08
GLP 1 RAs  Real World Patient Care Strategies for Type 2
The France Foundation
GLP 1 RAs Real World Patient Care Strategies for Type 2
50:57
A Changing Conversation  Delaying T1D Onset
The France Foundation
A Changing Conversation Delaying T1D Onset
44:02
Don't Delay, Check a CK: Early Diagnosis for Patients with DMD
The France Foundation
Don't Delay, Check a CK: Early Diagnosis for Patients with DMD
3:31
Multi-Disciplinary Care for Ambulatory versus Non-ambulatory patients with DMD
The France Foundation
Multi-Disciplinary Care for Ambulatory versus Non-ambulatory patients with DMD
2:14
Ongoing Role of Primary Care Providers in DMD Management
The France Foundation
Ongoing Role of Primary Care Providers in DMD Management
1:56
Early Screening and Therapeutic Options for Patients with DMD
The France Foundation
Early Screening and Therapeutic Options for Patients with DMD
3:02
I Have DMD: Am I a Candidate for Gene Therapy?
The France Foundation
I Have DMD: Am I a Candidate for Gene Therapy?
1:05
Managing Caregiving Expectations for Patients with DMD
The France Foundation
Managing Caregiving Expectations for Patients with DMD
1:22
How Does Gene Therapy Work for Patients with Duchenne Muscular Dystrophy?
The France Foundation
How Does Gene Therapy Work for Patients with Duchenne Muscular Dystrophy?
1:44
Managing Amyloidosis What You Need to Know Now and For the Future
The France Foundation
Managing Amyloidosis What You Need to Know Now and For the Future
1:00:52
The Delicate Balance of Brain Cholesterol: Animation 2 of 2
The France Foundation
The Delicate Balance of Brain Cholesterol: Animation 2 of 2
3:48
The Delicate Balance of Brain Cholesterol: Animation 1 of 2
The France Foundation
The Delicate Balance of Brain Cholesterol: Animation 1 of 2
3:15
Fall 2023 Conference Coverage: AAV Shedding
The France Foundation
Fall 2023 Conference Coverage: AAV Shedding
2:02
The Delicate Balance of Brain Cholesterol - TFF Satellite Symposium at AES 2023 Annual Meeting
The France Foundation
The Delicate Balance of Brain Cholesterol - TFF Satellite Symposium at AES 2023 Annual Meeting
2:12:06
Fall 2023 Conference Coverage: Impact of Combination Therapies for Neuromuscular Disorders
The France Foundation
Fall 2023 Conference Coverage: Impact of Combination Therapies for Neuromuscular Disorders
4:02
Fall 2023 Conference Coverage: Heterogeneity in Muscular Dystrophies
The France Foundation
Fall 2023 Conference Coverage: Heterogeneity in Muscular Dystrophies
4:57
Fall 2023 Conference Coverage: Registries and Natural History Studies
The France Foundation
Fall 2023 Conference Coverage: Registries and Natural History Studies
4:53
Fall 2023 Conference Coverage: Updates in Duchenne Muscular Dystrophy
The France Foundation
Fall 2023 Conference Coverage: Updates in Duchenne Muscular Dystrophy
4:59
Fall 2023 Conference Coverage: Functional Biomarkers for Muscular Dystrophy
The France Foundation
Fall 2023 Conference Coverage: Functional Biomarkers for Muscular Dystrophy
5:10
Fall 2023 Conference Coverage: Upcoming Therapies for LGMD
The France Foundation
Fall 2023 Conference Coverage: Upcoming Therapies for LGMD
3:09
Genetic Subtypes of LGMD - Animation
The France Foundation
Genetic Subtypes of LGMD - Animation
1:27
Limb Girdle Muscular Distrophy (LGMD) AAV Gene Therapy Animation
The France Foundation
Limb Girdle Muscular Distrophy (LGMD) AAV Gene Therapy Animation
2:29
Re-engaging Limb Girdle Muscular Distrophy (LGMD) Patients Into Care
The France Foundation
Re-engaging Limb Girdle Muscular Distrophy (LGMD) Patients Into Care
4:39
Preliminary Report on Gene Therapy for SGCB
The France Foundation
Preliminary Report on Gene Therapy for SGCB
0:51
Importance of Early Diagnosis in Limb Girdle Muscular Distrophy (LGMD)
The France Foundation
Importance of Early Diagnosis in Limb Girdle Muscular Distrophy (LGMD)
2:43
Accessibility of Genetic Testing Programs for Limb Girdle Muscular Distrophy (LGMD)
The France Foundation
Accessibility of Genetic Testing Programs for Limb Girdle Muscular Distrophy (LGMD)
0:33
LGMD Patient Resources
The France Foundation
LGMD Patient Resources
0:24
Limb-Girdle Muscular Dystrophy (LGMD): Natural History
The France Foundation
Limb-Girdle Muscular Dystrophy (LGMD): Natural History
4:07
Duchenne Muscular Dystrophy (DMD): Gene Therapy and How Muscle Responds
The France Foundation
Duchenne Muscular Dystrophy (DMD): Gene Therapy and How Muscle Responds
2:32
Limb-Girdle Muscular Dystrophy (LGMD): Diagnostic Algorithm
The France Foundation
Limb-Girdle Muscular Dystrophy (LGMD): Diagnostic Algorithm
5:03
Limb-Girdle Muscular Dystrophy: Which Gene Causes Which LGMD?
The France Foundation
Limb-Girdle Muscular Dystrophy: Which Gene Causes Which LGMD?
3:25
Duchenne Muscular Dystrophy (DMD) Treatment: The Bubble
The France Foundation
Duchenne Muscular Dystrophy (DMD) Treatment: The Bubble
2:45
Duchenne Muscular Dystrophy (DMD): Gene Therapy and Families
The France Foundation
Duchenne Muscular Dystrophy (DMD): Gene Therapy and Families
3:20
Providing a Medical Home for Kids with Rare Lung Disease: Recognizing and Caring for Kids
The France Foundation
Providing a Medical Home for Kids with Rare Lung Disease: Recognizing and Caring for Kids
1:19:54
Biomarker Driven Treatment of Metastatic Colorectal Cancer
The France Foundation
Biomarker Driven Treatment of Metastatic Colorectal Cancer
44:47
Stroke Prevention Through Afib Recognition and Treatment
The France Foundation
Stroke Prevention Through Afib Recognition and Treatment
41:01
A Spotlight on Rett Syndrome: Delayed Diagnosis, Patient/Caregiver Perspectives & Evolving Treatment
The France Foundation
A Spotlight on Rett Syndrome: Delayed Diagnosis, Patient/Caregiver Perspectives & Evolving Treatment
40:38